Nina Dedic

University of Novi Sad — RS

Neuroscience · Life Sciences

25h-index3.4kcitations57works7.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Stress Responses and Cortisol(17), Neurotransmitter Receptor Influence on Behavior(15), Receptor Mechanisms and Signaling(11), Tryptophan and brain disorders(11), Neuroscience and Neuropharmacology Research(10)

Publications57 total

The trace amine-associated receptor 1 regulates presynaptic dopamine function: evidence from preclinical studies and a phase 1b trial in patients with schizophrenia
Biological Psychiatry·2025Open Access
Influence of probiotics and deoxycholate on azathioprine transport in the PAMPA model: insights into pharmacomicrobiomics and interindividual variability in drug response
Frontiers in Pharmacology·2025· 3 citedOpen Access
Establishment and behavioural characterization of a novel constitutive P2X7 receptor knockout mouse line
Purinergic Signalling·2025· 2 citedOpen Access
5-HT1B receptor activation produces rapid antidepressant-like effects in rodents
Pharmacology Biochemistry and Behavior·2024· 4 cited
TAAR1 and 5-HT1B receptor agonists attenuate autism-like irritability and aggression in rats prenatally exposed to valproic acid
Pharmacology Biochemistry and Behavior·2024· 6 cited
<scp>TAAR1</scp> agonist ulotaront delays gastric emptying of solids in patients with schizophrenia and concurrent metabolic syndrome with prediabetes
Diabetes Obesity and Metabolism·2024· 5 citedOpen Access
SKA2 regulated hyperactive secretory autophagy drives neuroinflammation-induced neurodegeneration
Nature Communications·2024· 24 citedOpen Access
TAAR1 agonists improve glycemic control, reduce body weight and modulate neurocircuits governing energy balance and feeding
Molecular Metabolism·2024· 19 citedOpen Access
TAAR1 agonist ulotaront modulates striatal and hippocampal glutamate function in a state-dependent manner
Neuropsychopharmacology·2023· 16 citedOpen Access
Ulotaront: review of preliminary evidence for the efficacy and safety of a TAAR1 agonist in schizophrenia
European Archives of Psychiatry and Clinical Neuroscience·2023· 45 citedOpen Access
SKA2 regulated hyperactive secretory autophagy drives neuroinflammation-induced neurodegeneration
2023Open Access
Review of the TAAR1 Agonist Ulotaront: Part I—From Discovery to Clinic
CNS Spectrums·2023Open Access
TAAR1 Agonist Ulotaront Improves Glycemic Control and Reduces Body Weight in Rodent Models of Diabetes, Obesity, and Iatrogenic Weight Gain
CNS Spectrums·2023· 2 citedOpen Access
A low-burden non-invasive measurement of neuroplasticity: feasibility for use in early drug development trials
Neuroscience Applied·2023Open Access
In Vitro ADME and Preclinical Pharmacokinetics of Ulotaront, a TAAR1/5-HT1A Receptor Agonist for the Treatment of Schizophrenia
Pharmaceutical Research·2022· 13 citedOpen Access
Pharmacological Profile and Therapeutic Potential of Ulotaront, a Novel Candidate for the Treatment of Schizophrenia
Proceedings for Annual Meeting of The Japanese Pharmacological Society·2022Open Access
Ulotaront improves metabolic parameters in rodent models of weight gain and hyperglycemia
Neuroscience Applied·2022Open Access
Ulotaront, a novel TAAR1 agonist with 5-HT1A agonist activity, lacks abuse liability and attenuates cocaine cue-induced relapse in rats
Drug and Alcohol Dependence·2021· 15 citedOpen Access
Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies
International Journal of Molecular Sciences·2021· 93 citedOpen Access
Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia
ACS Medicinal Chemistry Letters·2021· 66 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Jan M. Deussing(22), Kenneth S. Koblan(15), Seth C. Hopkins(14), Mathias V. Schmidt(12), Wolfgang Wurst(11), Jakob Hartmann(11), Herta Flor(10), Alon Chen(8), Carsten T. Wotjak(7), Damián Refojo(6), Kerry J. Ressler(6), Michael Metzger(6), Linda J. Bristow(6), Nils C. Gassen(5), Klaus V. Wagner(5), Max L. Pöhlmann(5), Philip Jones(5), Claudia Kühne(5), Courtney Zeni(5), Mayumi Kimura(5)